Clinical Trials Browser

OTHER × bemcentinib × Other hematologic neoplasm × Clear all

NCT03824080 2021-12-21

Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute